Precision Medicine, a 503A pharmacy that fills prescriptions for telehealth companies nationwide, operates a sterile compounding facility in California, alongside the company’s operations in Bellmore, New York, and Boca Raton, Florida.
Sterile compounding is the most demanding part of pharmacy work. It covers preparations such as injectables and eye drops that bypass the body’s natural defenses, so any contamination can be dangerous. Facilities must meet USP chapter 797, which sets rules for clean rooms, air quality, staff garbing, training and environmental monitoring. Pharmacies handling hazardous drugs must also meet USP chapter 800.
Why the location matters
A pharmacy that ships medication across the country is also a logistics business. Distance adds transit time, and many sterile preparations travel cold. A West Coast site shortens the trip for patients in California and neighboring states and gives the company a third location if one site is disrupted.
Precision Medicine describes the aim as being “a single, redundant and dependable source” for its partners. It currently describes Bellmore as its headquarters and northern hub and Boca Raton as its southern hub.

Who it serves
The company does not run a walk-in counter. It fills prescriptions for direct-to-consumer telemedicine companies, receiving orders through software integrations and shipping directly to patients, often under the telehealth brand’s own packaging. Its formulary covers hormone therapy, peptides such as sermorelin, men’s and women’s health, weight management, dermatology, longevity and commercial medications.
Its sterile work includes injectable preparations; its non-sterile work covers capsules, tablets, sublinguals, creams, sprays and gummies made under USP chapter 795.
The licensing picture
A pharmacy in any state needs a separate license in each state it ships to. Precision Medicine says it holds licenses in 49 states. It is accredited by the National Association of Boards of Pharmacy and certified by LegitScript.
A note for patients
Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they reach patients. Patients in California who receive compounded medication by mail can check the pharmacy named on their label against the California State Board of Pharmacy’s license lookup.
For the company, the California site is a statement about where telehealth is heading: national demand, served from more than one coast.



